These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3742966

  • 1. [Collateral effects of anti-ulcer therapy with carbenoxolone. General considerations. A clinical case].
    Frabetti F, Zardi V, Grappa P, Dattola L, Bellodi G.
    Clin Ter; 1986 Jun 30; 117(6):455-62. PubMed ID: 3742966
    [No Abstract] [Full Text] [Related]

  • 2. Side-effects of carbonoxolone.
    Baron JH.
    Acta Gastroenterol Belg; 1983 Jun 30; 46(9-10):469-84. PubMed ID: 6673458
    [No Abstract] [Full Text] [Related]

  • 3. [Hypokalemic myopathy secondary to carbenoxolone ulcer therapy (case report)].
    Corsi FM, Galgani S, Giacanelli M, Piazza G.
    Riv Neurobiol; 1980 Jun 30; 26(3):350-6. PubMed ID: 7336082
    [No Abstract] [Full Text] [Related]

  • 4. Carbenoxolone and hypokalaemia.
    Metcalfe MJ, Entrican JH.
    Lancet; 1987 Dec 26; 2(8574):1525-6. PubMed ID: 2892083
    [No Abstract] [Full Text] [Related]

  • 5. Drugs for peptic ulcer.
    Jones FA, Hunt T.
    World J Surg; 1979 Sep 20; 3(5):659-60. PubMed ID: 516781
    [No Abstract] [Full Text] [Related]

  • 6. Carbenoxolone and hypokalaemic hypertension: case report.
    Celi FS, D'Erasmo E, Oddo CM, Aliberti G.
    Riv Eur Sci Med Farmacol; 1988 Nov 20; 10(5):383-4. PubMed ID: 3274721
    [No Abstract] [Full Text] [Related]

  • 7. Serum carbenoxolone: ulcer-healing and metabolic effects.
    Wright PA, Reed PI, Davies WA, St John DJ, Young GP, House FR, Gribble RJ, Baron JH.
    Scand J Gastroenterol Suppl; 1980 Nov 20; 65():41-8. PubMed ID: 6937940
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of ulcer with acetoxolon].
    Gabor M.
    Dtsch Med Wochenschr; 1985 Jun 28; 110(26):1057-8. PubMed ID: 4006763
    [No Abstract] [Full Text] [Related]

  • 9. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C.
    Clin Ter; 1979 Mar 31; 88(6):605-19. PubMed ID: 157245
    [No Abstract] [Full Text] [Related]

  • 10. Iatrogenic hypokalaemia.
    Haboubi NY, Barford AV, Asquith P.
    Practitioner; 1985 Apr 31; 229(1402):302. PubMed ID: 2986090
    [No Abstract] [Full Text] [Related]

  • 11. [Undesirable effects of Biogastrone in the treatment of peptic ulcer (author's transl)].
    Zelenková J, Toman R, Svoboda M, Svihovec J.
    Cesk Gastroenterol Vyz; 1976 Oct 31; 30(7):427-33. PubMed ID: 797473
    [No Abstract] [Full Text] [Related]

  • 12. [Double-blind study of proglumide, zolimidine and carbenoxolone in peptic ulcer and gastroduodenitis].
    Corazza GR, D'Ambro A, Grimoldi D.
    Minerva Dietol Gastroenterol; 1979 Oct 31; 25(1):47-58. PubMed ID: 156316
    [No Abstract] [Full Text] [Related]

  • 13. [Life-threatening hypokalemic paralysis in carbenoxolone therapy].
    Thorwirth V, Oberdalhoff HE, Ritter G.
    Nervenarzt; 1975 Jun 31; 46(6):322-4. PubMed ID: 1196451
    [No Abstract] [Full Text] [Related]

  • 14. [Controlled clinical study of the effectiveness of a new anti-ulcer drug: thiopropamine].
    Masoero G.
    Clin Ter; 1979 Aug 15; 90(3):261-72. PubMed ID: 399873
    [No Abstract] [Full Text] [Related]

  • 15. Carbenoxolone sodium for gastric ulcer.
    Med Lett Drugs Ther; 1975 Aug 01; 17(16):67-8. PubMed ID: 1097883
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of peptic ulcer with cytoprotective substances].
    Fortunat W.
    Wien Med Wochenschr; 1983 Aug 01; 133(4-5):94-8. PubMed ID: 6407215
    [No Abstract] [Full Text] [Related]

  • 17. Long-term therapy with carbenoxolone in the prevention of recurrence of gastric ulcer. Natural history and evolution of important side-effects and measures to avoid them.
    Ganguli PC, Mohamed SD.
    Scand J Gastroenterol Suppl; 1980 Aug 01; 65():63-71. PubMed ID: 6937941
    [Abstract] [Full Text] [Related]

  • 18. [Tolerance of carbenoxolone sodium in elderly patients (author's transl)].
    Hagenmüller F, Wurbs D, Classen M.
    Leber Magen Darm; 1977 Dec 01; 7(6):385-8. PubMed ID: 593029
    [Abstract] [Full Text] [Related]

  • 19. The pathogenesis of pseudohyperaldosteronism from carbenoxolone.
    Armanini D, Scali M, Zennaro MC, Karbowiak I, Wallace C, Lewicka S, Vecsei P, Mantero F.
    J Endocrinol Invest; 1989 May 01; 12(5):337-41. PubMed ID: 2671110
    [Abstract] [Full Text] [Related]

  • 20. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D, Cataldo MG, Paterna S, Bivona A, Barbarino C.
    Pharmatherapeutica; 1985 May 01; 4(3 Spec No):166-70. PubMed ID: 3903785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.